Sponsor Pipeline

Pharming Technologies B.V. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
2
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Phase 2
5
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05438407 Pediatric Patients Aged 4 to 11 Years With APDS APDS Active, Not Recruiting
NCT05693129 Pediatric Patients Aged 1 to 6 Years With APDS APDS Active, Not Recruiting
Phase 2
NCT06990529 Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation PIDs Linked to PI3K Recruiting
NCT05650229 Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease Primary Mitochondrial Disease Recruiting
NCT06897358 Leniolisib for Immune Dysregulation in CVID Common Variable Immunodeficiency (CVID) Active, Not Recruiting
NCT06549114 Leniolisib for Immune Dysregulation in PIDs Primary Immunodeficiency Disorders (PIDs) Active, Not Recruiting
NCT07514338 Open Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With… Mitochondrial Diseases Not Yet Recruiting
Get alerts when Pharming Technologies B.V.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free